New Chemotherapy Combination Shows Promise in Endometrial Cancer, Researchers Find

ScienceDaily (Mar. 19, 2010) — Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.

Go to ScienceDaily-New Chemotherapy Combination for details.
Feel good and keep smiling! Pat & Pattie

Liked this article? Share it! Information is power!

• 

cisplatin, endometrial cancer, gemcitabine, M.D. Anderson Cancer Center